Study Information
Study Details
View study details on clinicaltrials.gov.
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
The PREEMPT CRC study is a prospective multi-center observational study to validate a blood-based test for the early detection of colorectal cancer by collecting blood samples from average-risk participants who will undergo a routine screening colonoscopy
Freenome is using a type of artificial intelligence, called machine learning, to identify patterns of cell-free biomarkers in blood to detect cancer early. The purpose of this prospective multi-center observational study is to validate a blood-based test for the detection of colorectal cancer by collecting blood samples from average-risk participants who will undergo a routine screening colonoscopy.
Location:SIMR (Sacramento/Valley Area)
Please contact Debbie Jacobs jacobsDA@sutterhealth.org about study PREEMPT CRC
Principal Investigator
Co-Investigator(s)
Theodor Feinstat, MD, Andrew Hudnut, MD, Abdul M Khaleq, MD, Ian J Logan, MD